title: Closure of perianal fistula using adalimumab in a Crohn's disease patient naive to antitumor necrosis factor alpha antibodies.
authors.forename: Alberto
authors.initials: A
authors.lastname: Malesci
authors.forename: Erika
authors.initials: E
authors.lastname: Angelucci
authors.forename: Cristina
authors.initials: C
authors.lastname: Bonifacio
authors.forename: Orsola
authors.initials: O
authors.lastname: Sociale
authors.forename: Paolo
authors.initials: P
authors.lastname: Omodei
authors.forename: Alessandro
authors.initials: A
authors.lastname: Repici
authors.forename: Luca
authors.initials: L
authors.lastname: Balzarini
authors.forename: Silvio
authors.initials: S
authors.lastname: Danese
mesh_terms: D000068879:Adalimumab; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D003424:Crohn Disease / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D005260:Female; D006801:Humans; D012003:Rectal Fistula / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology*
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab